SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-058527
Filing Date
2018-02-26
Accepted
2018-02-26 16:29:34
Documents
3
Period of Report
2018-04-11
Effectiveness Date
2018-02-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d443482ddef14a.htm DEF 14A 314782
2 GRAPHIC g443482pc-1.jpg GRAPHIC 109792
3 GRAPHIC g443482pc-2.jpg GRAPHIC 145645
  Complete submission text file 0001193125-18-058527.txt   668242
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 18640939
SIC: 2836 Biological Products, (No Diagnostic Substances)